Balance Sheet Cellectis S.A.

Equities

ALCLS

FR0010425595

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:55:00 08/05/2026 BST			5-day change	1st Jan Change
3.198 ^EUR	-1.72%		-3.85%	-23.77%

05-06	European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading	MT
05-05	It's kicking off, but they're still talking

aa6a510644.CVy-53mTHIT0yLfF3HnrpqgdBaqb-cCBL0SNNtoK2tE.SAjf1BzVVM3CuNWRjCvT94VIV5jzyKLTRin8c51N77dTZc2dMaBa7cW__g

Published financial data: CELLECTIS S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	57.29M	19.17M	755K	41.5M	72.95M
Other Revenues, Total	8.25M	6.55M	8.44M	7.71M	6.64M
Total Revenues	65.54M	25.72M	9.19M	49.22M	79.59M
Cost of Goods Sold, Total	31.36M	1.77M	737K	-	-
Gross Profit	34.18M	23.95M	8.46M	49.22M	79.59M
Selling General & Admin Expenses, Total	37.87M	17.49M	16.81M	19.08M	19.79M
R&D Expenses	129M	97.5M	87.65M	90.54M	93.52M
Other Operating Expenses	-511K	-1.38M	800K	-849K	-638K
Other Operating Expenses, Total	166M	114M	105M	109M	113M
Operating Income	-132M	-89.67M	-96.8M	-59.56M	-33.08M
Interest Expense, Total	-5.34M	-3.79M	-5.31M	-7.45M	-8.11M
Interest And Investment Income	736K	1.12M	3.61M	11.28M	9.5M
Net Interest Expenses	-4.6M	-2.67M	-1.69M	3.82M	1.39M
Currency Exchange Gains (Loss)	9.73M	6.06M	4.22M	7.32M	-22.06M
Other Non Operating Income (Expenses)	442K	-12.33M	-1.12M	1K	-14.27M
EBT, Excl. Unusual Items	-127M	-98.6M	-95.4M	-48.4M	-68.02M
Gain (Loss) On Sale Of Investments	-	-	-20.57M	11.64M	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-500K	-	-
Other Unusual Items	1.53M	-	-	-	-
EBT, Incl. Unusual Items	-125M	-98.6M	-116M	-36.76M	-68.02M
Income Tax Expense	-	87K	371K	-	-423K
Earnings From Continuing Operations	-125M	-98.69M	-117M	-36.76M	-67.59M
Earnings Of Discontinued Operations	-	-15.34M	8.39M	-	-
Net Income to Company	-125M	-114M	-108M	-36.76M	-67.59M
Minority Interest	10.91M	7.89M	7.38M	-	-
Net Income - (IS)	-114M	-106M	-101M	-36.76M	-67.59M
Net Income to Common Incl Extra Items	-114M	-106M	-101M	-36.76M	-67.59M
Net Income to Common Excl. Extra Items	-114M	-90.79M	-109M	-36.76M	-67.59M
Per Share Items
Net EPS - Basic	-2.55	-2.33	-1.77	-0.41	-0.67
Basic EPS - Continuing Operations	-2.55	-1.99	-1.92	-0.41	-0.67
Basic Weighted Average Shares Outstanding	44.82M	45.55M	57.01M	90.57M	100M
Net EPS - Diluted	-2.55	-2.33	-1.77	-0.41	-0.67
Diluted EPS - Continuing Operations	-2.55	-1.99	-1.92	-0.41	-0.67
Diluted Weighted Average Shares Outstanding	44.82M	45.55M	57.01M	90.57M	100M
Normalized Basic EPS	-1.52	-1.18	-0.92	-0.33	-0.42
Normalized Diluted EPS	-1.52	-1.18	-0.92	-0.33	-0.42
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-125M	-79.77M	-86.75M	-48.25M	-21.75M
EBITA	-132M	-89.67M	-96.8M	-59.56M	-33.08M
EBIT	-132M	-89.67M	-96.8M	-59.56M	-33.08M
Total Revenues (As Reported)	67.07M	25.72M	9.19M	49.22M	79.59M
Effective Tax Rate - (Ratio)	-	-0.09	-0.32	-	0.62
Normalized Net Income	-68.24M	-53.73M	-52.24M	-30.25M	-42.51M
Interest on Long-Term Debt	4.98M	3.42M	3.06M	2.64M	2.22M
Non-Cash Pension Expense	26K	43K	90K	1.28M	42K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	129M	97.5M	87.65M	90.54M	93.52M
Stock-Based Comp., R&D Exp. (Total)	10.85M	4.1M	3.95M	2.03M	4.14M
Stock-Based Comp., SG&A Exp. (Total)	2.27M	1.94M	1.28M	1.14M	1.97M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	13.12M	6.04M	5.23M	3.17M	6.11M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	186M	89.79M	137M	143M	61.53M
Short Term Investments	-	-	-	-	145M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	186M	89.79M	137M	143M	206M
Accounts Receivable, Total	20.36M	772K	569K	6.71M	14.4M
Other Receivables	10.71M	16.8M	22.56M	16.32M	10.92M
Notes Receivable	-	7.91M	-	-	-
Total Receivables	31.07M	25.48M	23.13M	23.04M	25.32M
Inventory	-	-	-	-	-
Prepaid Expenses	8.17M	6.23M	5.72M	3.43M	1.93M
Restricted Cash	499K	-	-	-	2.05M
Other Current Assets, Total	50K	22.31M	67.45M	117M	564K
Total Current Assets	225M	144M	233M	287M	236M
Gross Property Plant And Equipment	195M	164M	168M	167M	176M
Accumulated Depreciation	-47.18M	-55.72M	-75.41M	-91.38M	-114M
Net Property Plant And Equipment	148M	108M	92.74M	75.86M	62.45M
Long-term Investments	1.72M	4.09M	-	-	988K
Other Intangibles, Total	1.85M	718K	671K	1.12M	535K
Accounts Receivable Long-Term	-	-	-	-	1.8M
Deferred Tax Assets Long-Term	-	-	-	382K	382K
Other Long-Term Assets, Total	4.8M	4.7M	7.85M	19.11M	22.32M
Total Assets	382M	261M	334M	384M	325M
Liabilities
Accounts Payable, Total	23.76M	21.46M	19.07M	18.66M	17.28M
Accrued Expenses, Total	12.55M	12.48M	9.37M	8.85M	10.85M
Current Portion of Long-Term Debt	2.25M	4.97M	5.16M	4.84M	4.09M
Current Portion of Leases	8.33M	7.87M	8.5M	8.38M	7.7M
Unearned Revenue Current, Total	301K	59K	110M	112M	96.8M
Other Current Liabilities	2.16M	16.16M	2.72M	13.37M	9.04M
Total Current Liabilities	49.35M	63M	155M	166M	146M
Long-Term Debt	18.77M	13.57M	27M	40.8M	47.18M
Long-Term Leases	71.53M	49.36M	42.95M	34.24M	27.72M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	158K	-	-
Other Non Current Liabilities	5.96M	9.35M	24.33M	11.2M	28.17M
Total Liabilities	146M	135M	250M	253M	249M
Common Stock, Total	2.94M	2.96M	4.36M	5.89M	5.9M
Additional Paid In Capital	935M	583M	523M	494M	437M
Retained Earnings	-698M	-440M	-406M	-330M	-334M
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-18.02M	-28.6M	-36.69M	-39.54M	-33.32M
Total Common Equity	221M	118M	84.7M	131M	75.9M
Minority Interest	15.18M	7.97M	-	-	-
Total Equity	236M	126M	84.7M	131M	75.9M
Total Liabilities And Equity	382M	261M	334M	384M	325M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	45.48M	45.68M	71.75M	72.09M	72.59M
ECS Total Common Shares Outstanding	45.48M	45.68M	71.75M	72.09M	72.34M
Book Value / Share	4.87	2.58	1.18	1.82	1.05
Tangible Book Value	219M	117M	84.02M	130M	75.37M
Tangible Book Value Per Share	4.82	2.57	1.17	1.8	1.04
Total Debt	101M	75.77M	83.61M	88.27M	86.69M
Net Debt	-84.76M	-14.02M	-53.1M	-54.98M	-120M
Minority Interest, Total (Incl. Fin. Div)	15.18M	7.97M	-	-	-
Account Code - Inventory Valuation	5	5	3	3	3
Inventories - Raw Materials, Total	-	-	-	-	-
Land - (BS)	22.43M	17.74M	18.54M	18.14M	20.92M
Machinery, Total	80.55M	77.76M	78.46M	80.32M	81.67M
Full Time Employees	294	231	216	216	224
Part Time Employees	6	6	5	6	5
Accumulated Allowance for Doubtful Accounts (Supple)	29K	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-114M	-106M	-101M	-36.76M	-67.59M
Depreciation & Amortization - CF	16.27M	17.94M	18.45M	19.09M	18.84M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	16.27M	17.94M	18.45M	19.09M	18.84M
Amortization of Deferred Charges, Total - (CF)	304K	492K	69K	758K	1.23M
(Gain) Loss From Sale Of Asset	2K	1.61M	-	21K	1K
Stock-Based Compensation (CF)	13.12M	6.04M	5.23M	3.17M	6.11M
Net Cash From Discontinued Operations	-	-18.6M	-3.64M	-	-
Other Operating Activities, Total	-15.89M	16.93M	7.34M	-16.95M	43.61M
Change In Accounts Receivable	-5.83M	-3.19M	2.25M	52.6M	-5.02M
Change In Inventories	1.6M	-	-	-	-
Change In Accounts Payable	-444K	3.25M	-6.3M	2.06M	-3.26M
Change in Unearned Revenues	-139K	23K	59.15M	5.75M	-28.88M
Change in Other Net Operating Assets	654K	-5.81M	-6.24M	-6.73M	-4.43M
Cash from Operations	-105M	-87.44M	-24.75M	22.99M	-39.4M
Capital Expenditure	-19.73M	-2.43M	-1.07M	-2.58M	-2.36M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-13K	-10K	-	-1.26M	-1.17M
Investment in Marketable and Equity Securities, Total	27.02M	126K	-12.87M	-98.96M	-25.95M
Other Investing Activities, Total	-1K	-446K	-1.56M	-1K	-1K
Cash from Investing	7.28M	-2.76M	-15.51M	-103M	-29.48M
Long-Term Debt Issued, Total	-	5.75M	29.67M	23.2M	-
Total Debt Issued	-	5.75M	29.67M	23.2M	-
Long-Term Debt Repaid, Total	-12.46M	-12.35M	-16.19M	-16.06M	-16.19M
Total Debt Repaid	-12.46M	-12.35M	-16.19M	-16.06M	-16.19M
Issuance of Common Stock	56.47M	-	69.98M	83.03M	44K
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	3.52M	7.75M	-600K	-1.05M	-612K
Cash from Financing	47.52M	1.14M	82.86M	89.11M	-16.76M
Foreign Exchange Rate Adjustments	-5.75M	-3.36M	884K	-2.75M	3.93M
Miscellaneous Cash Flow Adjustments	-	-	-1K	1K	-
Net Change in Cash	-55.51M	-92.42M	43.49M	6.54M	-81.72M
Supplemental Items
Cash Interest Paid	355K	332K	333K	847K	612K
Levered Free Cash Flow	-60.24M	-39.22M	7.92M	-58.67M	-25.28M
Unlevered Free Cash Flow	-56.9M	-36.85M	11.23M	-54.01M	-20.22M
Change In Net Working Capital	-15.78M	2.85M	-49.05M	35.96M	22.18M
Net Debt Issued / Repaid	-12.46M	-6.6M	13.48M	7.14M	-16.19M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-19.41	-17.42	-20.32	-10.37	-5.84
Return on Total Capital	-21.95	-20.79	-32.7	-19.21	-10.83
Return On Equity %	-45.88	-54.46	-110.94	-34.08	-65.33
Return on Common Equity	-45.22	-53.52	-108.01	-34.08	-65.33
Margin Analysis
Gross Profit Margin %	52.15	93.11	91.98	100	100
SG&A Margin	57.78	68.01	182.88	38.78	24.86
EBITDA Margin %	-190.65	-310.1	-943.62	-98.04	-27.33
EBITA Margin %	-201.71	-348.57	-1.05K	-121	-41.56
EBIT Margin %	-201.71	-348.57	-1.05K	-121	-41.56
Income From Continuing Operations Margin %	-190.88	-383.64	-1.27K	-74.69	-84.92
Net Income Margin %	-174.23	-412.61	-1.1K	-74.69	-84.92
Net Avail. For Common Margin %	-174.23	-352.95	-1.19K	-74.69	-84.92
Normalized Net Income Margin	-104.11	-208.88	-568.24	-61.47	-53.41
Levered Free Cash Flow Margin	-91.9	-152.47	86.11	-119.2	-31.76
Unlevered Free Cash Flow Margin	-86.81	-143.27	122.19	-109.74	-25.4
Asset Turnover
Asset Turnover	0.15	0.08	0.03	0.14	0.22
Fixed Assets Turnover	0.45	0.2	0.09	0.58	1.15
Receivables Turnover (Average Receivables)	4.49	1.81	1.13	11.4	6.91
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	4.57	2.28	1.5	1.73	1.62
Quick Ratio	4.39	1.7	1.03	1	1.59
Operating Cash Flow to Current Liabilities	-2.12	-1.39	-0.16	0.14	-0.27
Days Sales Outstanding (Average Receivables)	81.33	201.18	324.15	32.11	52.82
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	-	4.66K	10.04K	-	-
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	42.66	60.16	98.72	67.37	114.22
Total Debt / Total Capital	29.9	37.56	49.68	40.25	53.32
LT Debt/Equity	38.18	49.97	82.58	57.27	98.68
Long-Term Debt / Total Capital	26.77	31.2	41.56	34.22	46.07
Total Liabilities / Total Assets	38.11	51.79	74.66	65.84	76.63
EBIT / Interest Expense	-24.77	-23.68	-18.24	-7.99	-4.08
EBITDA / Interest Expense	-21.72	-18.94	-14.76	-5.43	-1.76
(EBITDA - Capex) / Interest Expense	-25.42	-19.58	-14.97	-5.78	-2.05
Total Debt / EBITDA	-0.87	-1.06	-1.07	-2.18	-6.09
Net Debt / EBITDA	0.73	0.2	0.68	1.36	8.4
Total Debt / (EBITDA - Capex)	-0.74	-1.02	-1.05	-2.05	-5.22
Net Debt / (EBITDA - Capex)	0.62	0.19	0.67	1.28	7.21
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-20.51	-33.35	-64.26	435.37	61.72
Gross Profit, 1 Yr. Growth %	-25.98	-34.83	-64.7	482.04	61.72
EBITDA, 1 Yr. Growth %	52.21	-19.14	8.75	-43.92	-54.92
EBITA, 1 Yr. Growth %	55.1	-13.35	7.96	-38.03	-44.46
EBIT, 1 Yr. Growth %	55.1	-13.35	7.96	-38.03	-44.46
Earnings From Cont. Operations, 1 Yr. Growth %	28.34	2	18.39	-68.54	83.87
Net Income, 1 Yr. Growth %	40.86	-7.06	-4.79	-63.62	83.87
Normalized Net Income, 1 Yr. Growth %	53.71	8.42	-2.78	-41.6	85.02
Diluted EPS Before Extra, 1 Yr. Growth %	33.51	3.97	-3.69	-78.64	64.4
Accounts Receivable, 1 Yr. Growth %	293.75	-96.21	-26.3	1.08K	114.45
Inventory, 1 Yr. Growth %	-	-	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	1.89	-27.23	-14.05	-18.2	-17.69
Total Assets, 1 Yr. Growth %	-18.62	-31.63	27.97	14.74	-15.34
Tangible Book Value, 1 Yr. Growth %	-22.24	-46.57	-28.34	54.62	-41.99
Common Equity, 1 Yr. Growth %	-22.02	-46.69	-28.21	54.71	-42.07
Cash From Operations, 1 Yr. Growth %	30.28	-16.37	-71.7	-192.9	-271.39
Capital Expenditures, 1 Yr. Growth %	-56.82	-86.89	-55.86	140.73	-8.63
Levered Free Cash Flow, 1 Yr. Growth %	-41.27	-11.67	-120.18	-802.07	-143.3
Unlevered Free Cash Flow, 1 Yr. Growth %	-43.28	-11.83	-130.48	-562.68	-132.06
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	68.85	-34.28	-51.2	38.32	194.24
Gross Profit, 2 Yr. CAGR %	71.68	-35.52	-52.03	43.35	206.8
EBITDA, 2 Yr. CAGR %	3.41	51.66	-6.23	-22.22	-49.72
EBITA, 2 Yr. CAGR %	3.44	45.58	-3.28	-18.5	-41.33
EBIT, 2 Yr. CAGR %	3.44	45.58	-3.28	-18.5	-41.33
Earnings From Cont. Operations, 2 Yr. CAGR %	4.21	35.71	9.89	-38.97	-23.94
Net Income, 2 Yr. CAGR %	5.76	14.42	-5.93	-41.15	-18.22
Normalized Net Income, 2 Yr. CAGR %	7.65	77.37	2.67	-24.96	-18.91
Diluted EPS Before Extra, 2 Yr. CAGR %	2.86	50.76	0.12	-54.65	-40.75
Accounts Receivable, 2 Yr. CAGR %	162.32	-61.36	-83.28	194.9	403.03
Inventory, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	46.25	-13.89	-20.91	-16.15	-17.94
Total Assets, 2 Yr. CAGR %	-9.59	-25.41	-6.47	21.17	-1.44
Tangible Book Value, 2 Yr. CAGR %	-16.4	-35.54	-38.12	5.26	-5.29
Common Equity, 2 Yr. CAGR %	-16.2	-35.53	-38.14	5.39	-5.33
Cash From Operations, 2 Yr. CAGR %	22.97	4.38	-51.35	-48.73	26.18
Capital Expenditures, 2 Yr. CAGR %	23.61	-76.52	-75.94	3.08	48.31
Levered Free Cash Flow, 2 Yr. CAGR %	1.99	-30.78	-57.78	22.3	73.96
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.55	-32.27	-48.16	21.06	31.61
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	45.15	3.82	-46.36	8.44	45.72
Gross Profit, 3 Yr. CAGR %	22.29	27.35	-47.25	10.22	49.23
EBITDA, 3 Yr. CAGR %	6.68	-11.95	35.74	-21.21	-35.16
EBITA, 3 Yr. CAGR %	7.95	-10.13	31.77	-16.82	-28.28
EBIT, 3 Yr. CAGR %	7.95	-10.13	31.77	-16.82	-28.28
Earnings From Cont. Operations, 3 Yr. CAGR %	12.3	-5.03	29.67	-27.57	-11.85
Net Income, 3 Yr. CAGR %	13.22	1.3	7.62	-31.47	-13.96
Normalized Net Income, 3 Yr. CAGR %	14.41	-3.01	45.16	-15.17	-7.51
Diluted EPS Before Extra, 3 Yr. CAGR %	9.73	-6.13	29.84	-40.18	-30.33
Accounts Receivable, 3 Yr. CAGR %	89.95	-36.1	-52.08	-30.91	165.19
Inventory, 3 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	145.33	15.89	-13.94	-20.02	-16.66
Total Assets, 3 Yr. CAGR %	-8.63	-17.63	-10.7	0.13	7.52
Tangible Book Value, 3 Yr. CAGR %	-18.68	-27.99	-33.23	-16.03	-13.7
Common Equity, 3 Yr. CAGR %	-18.53	-27.93	-33.17	-16.03	-13.67
Cash From Operations, 3 Yr. CAGR %	15.34	8.14	-32.44	-39.64	-23.34
Capital Expenditures, 3 Yr. CAGR %	61.14	-42.69	-71.02	-48.16	-0.98
Levered Free Cash Flow, 3 Yr. CAGR %	14.94	-12.18	-54.1	9.73	-13.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.8	-13.16	-48.1	8.92	-18.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.03	-5.27	-15.57	16.44	5.97
Gross Profit, 5 Yr. CAGR %	-8.96	-5.09	-14.67	33.52	6.68
EBITDA, 5 Yr. CAGR %	13.85	-2.28	-3.36	-16.21	-8.91
EBITA, 5 Yr. CAGR %	14.46	-0.65	-1.63	-13.58	-4.81
EBIT, 5 Yr. CAGR %	14.46	-0.65	-1.63	-13.58	-4.81
Earnings From Cont. Operations, 5 Yr. CAGR %	13.22	-0.98	5.75	-20.42	4.76
Net Income, 5 Yr. CAGR %	11.17	1.33	5.13	-18.48	-3.57
Normalized Net Income, 5 Yr. CAGR %	10.17	-2.34	2.77	-12.47	20.01
Diluted EPS Before Extra, 5 Yr. CAGR %	5.95	-6.46	-0.11	-29.83	-5.13
Accounts Receivable, 5 Yr. CAGR %	41.21	-22.45	-28.15	17.81	22.73
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	54.39	71.72	55.99	1.82	-15.57
Total Assets, 5 Yr. CAGR %	2.88	-4.73	-7.77	-3.88	-7.11
Tangible Book Value, 5 Yr. CAGR %	-4.16	-14.95	-27.1	-16.18	-23.21
Common Equity, 5 Yr. CAGR %	-4.1	-14.94	-27.03	-16.1	-23.18
Cash From Operations, 5 Yr. CAGR %	26.16	10.82	-18.34	-19.77	-13.26
Capital Expenditures, 5 Yr. CAGR %	7.57	0.4	-25.63	-27.52	-44.31
Levered Free Cash Flow, 5 Yr. CAGR %	35.33	15.09	-27.56	0.26	-20.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.81	13.67	-22.29	-0.82	-24.12